Document is current
Any future updates will be listed below
-
Authors
Han, ShaoWei
Deng, ZiJie
Cheung, KaShing
Lyu, Tao
Chan, PuiLing
Li, Ying
Ni, Li
Luo, XiaPeng
Li, Kuan
-
Funding
Funding for this research was provided by:
the Health Commission Grant of Guangdong Province, China (ref. no. B2021239)
the Shenzhen Science and Technology Program (Grant Nos. JCYJ20190807150005699 and RCBS20200714115000009)
the Shenzhen Key Medical Discipline Construction Fund (Grant No. SZXK059)
the Shenzhen Key Laboratory of Prevention and Treatment of Severe Infections (Grant No. ZDSYS20200811142804014)
the National Natural Science Foundation of China (Grant No. 81903581)
- License Information
-
More Information
Article History
Received: 10 February 2023
Accepted: 4 July 2023
First Online: 7 July 2023
Declarations
:
: The trial is being conducted in compliance with the current version of the Declaration of Helsinki and the good clinical practice guidelines. This study received ethics approval from Ethics Committee of Shenzhen Hospital of the University of Hong Kong (approval number: [2022] 015). All participants will sign informed consent forms, consenting to initial assessments and participation in this study.
: Not applicable.
: The authors declare no competing interests.
